Efficacy of Optison Echo Contrast to Detect Thrombus in Left Atrial Appendage

• Status: Completed
• Trial end date: 2018-05-01
• Target enrollment: 0
• Participant gender: All

Summary

The investigators intend to determine if using Optison echocardiography contrast increases sensitivity and specificity of detecting left atrial appendage thrombus in transesophageal echocardiography studies as opposed to standard 2D and 3D TEE imaging without the use of echo contrast.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Utah

Criteria

Inclusion Criteria:

• > 18 years old

• Cognitively sound and able to provide informed consent

• Indicated for TEE as a standard clinical procedure for evaluation of cardiac health status.

Exclusion Criteria:

• Contraindicated for Optison administration

• Known right-to-left or bi-directional cardiac shunts

• Hypersensitivity to perflutren, blood, blood products or albumen

• Women who are pregnant

• Removal of Left Atrial Appendage

• Not able to provide informed consent